General methods
All reactions were carried out at room temperature. The anhydrous solvents used in oligonucleotide synthesis were bought from Aldrich Chemical Company and used as received. 8 ) were purchased from Sigma-Genosys and purified by polyacrylamide gel electrophoresis followed by extraction of the crushed gel with a tris/EDTA (1 mM/1mM) solution and desalting with a reverse phase C18 Sep-Pak cartridge. Modified cereus neutral protease (CNP E151C ), fluorogenic peptide substrate and phosphoramidate inhibitor were prepared as previously reported [Saghatelian, A.; et al. J. Am. Chem. Soc. 125, 344, (2003) ]. Fluorescence measurements were performed with a microplate reader (Genios, Tecan Instruments, λ ex = 365 nm, λ em = 460 nm) using black 96 well plates with measurements taken approximately every 28 seconds (for graphical clarity, only data points at 2.5 min intervals are shown). Total reaction volumes of 100 µL were used in all enzyme reactions. HPLC purifications of DNA-Inhibitor strands (DI) and DNA strands for enzyme modifications were performed on a Zorbax extend C18 column using a binary gradient (Sovent A: 0.1 M triethylammonium acetate, pH 7.5; Solvent B: A + 80% acetonitrile; gradient: 0-25% B over 30 minutes, Flow rate: 1 mL/min). Anion exchange chromatography was used to purify the DNA-Enzyme (DE) conjugates using Mono Q HR 5/5, ÄKTA purifier, Pharmacia, (Binary gradient -Solvent A: 100 mM Tris, 50 mM CaCl 2 , 2.5 µM Zn(ClO 4 ) 2 ; Solvent B: A + 1 M NaCl; 0% B 30 minutes, 0-100% B 30 minutes, flow rate 1 mL/min). MALDI-TOF mass spectrometry was performed using THAP matrix (2,4,6-trihydroxyacetophenone monohydrate) (97 µmol), ammonium citrate (29 µmol), acetonitrile:water (1 mL, 1:1).
Preparation of disulfide activated DNA (1) for reaction with CNP E151C to form DE (see main text for DNA sequence)
The 3'-sulfhydryl DNA strand (Ultramild DNA synthesis, Glen Research) was prepared using a 3'-disulphide modified column (C3-SS-CPG, Glen Research) on an automated synthesizer. The oligonucleotide was deprotected and cleaved from the solid support using K 2 CO 3 /methanol (0.5 M, 0.5 mL methanol) for 4 hr. Following deprotection and cleavage the solvent was removed and the dried material was redissolved in H 2 O/methanol (60% methanol, 0.3 mL) and treated with an aqueous solution of tricarboxyethylphosphine (50 µL, 10 µmol, pH 8.0) for 30 min. The resulting solution was concentrated (3000 MW, Micron YM-3 spin column, 45 min, 14,000 g) and treated with an acetonitrile/H 2 O (1:1) solution of 2,2'-dithiopyridine (300 µL, 15 µmol) and concentrated again (3000 MW, Micron YM-3 spin column, 60 minutes). The modified oligonucleotide was purified by polyacrylamide gel electrophoresis followed by extraction of the crushed gel with a tris/EDTA (1 mM/1mM) solution, for 18 hr, and then desalted with a reverse phase C18 Sep-Pak cartridge. The oligonucleotide was further purified by RP-HPLC (retention time = 20 min), desalted (reverse phase C18 Sep-Pak cartridge) and characterized by MALDI-MS. Mass calcd: 13698.7, Mass obs: 13711.9.
Preparation of DNA-enzyme conjugate (DE)
To a solution of CNP E151C (20 µL, 3.2 nmol) in buffer (20 µL, 50 mM Tris, 300 nM NaCl, pH 8) was added 1 (16 µL, 3.8 nmol). The mixture was placed at 4 o C for 18 hr and then purified by anion exchange chromatography. The resulting DE was identified by apparent molecular weight using SDS polyacrylamide gel electrophoresis (Fig. 1S ).
Preparation of DNA-inhibitor conjugates (DI

1
, DI 2 , DI 3 ) DNA strands were prepared (Ultramild DNA synthesis, Glen Research) on a solid support (CPG, Glen Research) using an automated DNA synthesizer. The C3 linker (Glen Research) was placed at the 5' end of the oligonucleotide to serve as a spacer between the DNA sequence and the inhibitor. While attached to the solid support, the 5' end of the oligonucleotide was modified by adding reagents via two syringes attached at either end of the CPG support column.
A solution of 2-cyanoethyldiispropylchlorophosphoramidite (0.2 M) and diisopropylethylamine (0.2 M) in CH 2 Cl 2 (0.5 mL) was injected into the column and allowed to react for 20 min. Following washing of the column with acetonitrile, an acetonitrile/H 2 O (9:1, 3 mL) solution of tetrazole (0.45 M) was permitted into the column and allowed to react for 20 minutes. Following washing with acetonitrile, the CPG column was treated with an acetonitrile/CCl 4 (1:1, 0.2 mL) and diisopropylethylamine (0.6 M) solution of H 2 N-LeuTrpOCH 3 (50 mg, 0.15 mmol). This mixture was allowed to react for 18 hr. After washing with acetonitrile and drying, the oligonucleotide was deprotected and cleaved from the solid support by stirring the CPG beads with K 2 CO 3 (0.5 M, 0.5 mL methanol) for 4 hr. Following deprotection and cleavage, the oligonucleotide was purified by polyacrylamide gel electrophoresis followed by extraction of the crushed gel with a tris/EDTA (1 mM/1mM) solution, for 18 hr, and then desalting with a reverse phase C18 Sep-Pak cartridge.
Additional purification was performed by HPLC (retention time = 22 min) and the resulting oligonucleotide was desalted (reverse phase C18 Sep-Pak cartridge) and characterized by MALDI ON-OFF switch cycle (Fig. 3 -main text) The five panels shown in Fig. 2S are plots of the fluorescence vs time data collected from five wells that were set up in the following fashion. Solution conditions: Tris/HCl (20 mM, pH 7.4), MgCl 2 (50 mM), DE (2 nM), input DNA (50 nM), fluorogenic substrate (80 µM), 100 µL total volume. Initially, DI 2 was added to all wells to establish the starting architecture DE-DI 2 . These wells were allowed to incubate for 60 minutes. At t = 0 min (Fig. 2S: Panel 1) substrate was added to well 1. After 10 min of data acquisition, D 6 was added to wells 2-5, which were allowed to incubate for 10 min. At t = 20 min (Fig.  2S : Panel 2), substrate was added to well 2. After 10 min of acquisition time, DI 2 was added to wells 3-5, which were allowed to incubate 10 min. At t = 40 min ( Fig. 2S : Panel 3), substrate was added to well 3. After 10 min of acquisition time, D 6 was added to wells 4 and 5, which were allowed to incubate for 10 min. At t = 60 min (Fig. 2S: Panel 4) , substrate was added to well 4. After 40 min of acquisition time, DI 2 was added to well 5, which was allowed to incubate for 10 min. At t = 110 min (Fig.  2S : Panel 5), substrate was added to well 5. Therefore, the state of the enzyme at each cycle was read by rates of substrate turnover in individual wells to obtain the five separate states shown in Fig. 3 of the main text, and as panels 1 to 5 in Fig. 2S . Alternatively, experiments were performed in which the switching was performed in the presence of substrate (Fig. 3S) . 
Logic gates (OR, AND, NOR) -full time course plots and control studies
By definition the AND gate has a true (1) output only when both inputs are true (present in the reaction mixture). The following control reactions were performed to establish that only the correct combinations of DNA inputs would turn on the enzyme (Fig. 6S) 
An alternative AND gate architecture
To illustrate the potential generality of logic gate programming, we show here the results for an AND gate constructed using a different approach (Fig. 7S) . For enzyme activation this method utilizes cooperative binding of two input strands to the allosteric α-loop of DE 2 -DI 1 enzyme complex. The DE 2 used here in combination with DI 1 is described by the following architectural parameters (α = 20, β = 2, γ = 18, δ = 0, ε = 0). The DE 2 strand is 6 bases shorter than the one discussed in the main text, forming an α-loop of 20 bases that interacts with the two incoming 10-mers, Fig. 4b (main text) corresponds to the gate response at 7 min reaction time when the fluorescence is at least twice the arbitrary threshold (set at 1 unit fluorescence). Figure 4S . The OR logic gate: The bar graph in Fig. 4a (main text) corresponds to the gate response at 60 min reaction time when the fluorescence is at least twice the arbitrary threshold (set at 1 unit fluorescence). It should be noted that because of the significant difference between the ON and OFF enzyme states, a lower threshold can be readily used to for faster (<10 min) output assignments.
DNA-encoded intrasterically regulated enzymes as diagnostic tools for sensitive detection of label-free nucleic acids
Because of the built-in signal amplification capacity (enzyme turnover), the DNA-encoded intrasterically regulated enzymes can be used for highly sensitive, rapid, and PCR-independent detection of label-free nucleic acid sequences. Figure 8S shows an example in which 50 pM (5 fmol) or 1 pM (100 amol) of an HIV target DNA were distinguished from background at 20 or 100 minutes of amplification/reaction time, respectively. 
